Evidence map›Paper›PMID 40619995›Full record

ArticleJournal of extracellular vesicles2025

A 96-Well Ultrafiltration Approach for the High-Throughput Proteome Analysis of Extracellular Vesicles Isolated From Conditioned Medium.

Jarne Pauwels, Tessa Van de Steene, Freya De Muyer, Danaë De Pauw, Femke Baeke, Sven Eyckerman, Kris Gevaert

Abstract read
In one paragraph

Article in Journal of extracellular vesicles, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jarne PauwelsVIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium.ORCID https://orcid.org/0000-0002-8525-7109
Tessa Van de SteeneVIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium.ORCID https://orcid.org/0000-0001-7915-2055
Freya De MuyerVIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium.ORCID https://orcid.org/0009-0008-2311-1965
Danaë De PauwVIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium.ORCID https://orcid.org/0009-0001-4093-6802
Femke BaekeGhent University Expertise Center for Transmission Electron Microscopy and VIB BioImaging Core, Ghent, Belgium.ORCID https://orcid.org/0000-0002-0761-9338
Sven EyckermanVIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium.ORCID https://orcid.org/0000-0001-7525-0096
Kris GevaertVIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium.

Funding

Bijzonder Onderzoeksfonds UGent 01IB3623Fonds Wetenschappelijk Onderzoek S006319NGhent University Concerted Research Actions 01G03121
6 · The paper itself

Abstract

Extracellular vesicles (EVs), nanoscale vesicles that are secreted by cells, are critical mediators of intercellular communication and play a crucial role in diverse pathologies such as cancer development. Therefore, EVs are regarded as having high potential in the clinic, both for diagnostic and therapeutic applications. Unfortunately, EVs reside in complex biofluids and their consistent preparation at sufficient purity for mass spectrometry-based proteomics has proven to be challenging, especially when increased high-throughput is required. Here, we describe the incorporation of our previously reported filter-aided EV enrichment (FAEVEr) strategy for the separation of EVs from conditioned medium, from harvest to proteomic analysis completely to a streamlined 96-well format. We compared our approach with ultracentrifugation, the most widely used method for EV enrichment, in terms of protein identifications, consistency, reproducibility and overall performance, including the invested time, resources and required expertise. In addition, our results show that including relative high percentages of Tween-20, a mild detergent, markedly improves the final purity of the EV proteome by removing the bulk of non-EV proteins (e.g., serum proteins) and significantly increases the number of identified transmembrane proteins. Moreover, our FAEVEr 96-well strategy improves the overall reproducibility with a consistent number of protein identifications and decreased number of missing values across replicates. This promotes the validity and comparability between results, which is essential in both a clinical and research setting, where consistency is paramount.

Indexed as

Extracellular VesiclesProteomeProteomicsCulture Media, ConditionedHigh-Throughput Screening AssaysHumansReproducibility of ResultsUltrafiltrationCulture Media, ConditionedProteome300 kDa MWCO 96‐well ultrafiltrationconditioned mediumproteomicsTween‐20

Identifiers

PMID40619995
PMCPMC12230347

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.